ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 21 filers reported holding ESSA PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,115,000 | -1.7% | 284,050 | 0.0% | 1.35% | +11.2% |
| Q1 2021 | $8,252,000 | +143.5% | 284,050 | 0.0% | 1.21% | +173.6% |
| Q4 2020 | $3,389,000 | +81.0% | 284,050 | +4.7% | 0.44% | +21.0% |
| Q3 2020 | $1,872,000 | +72.5% | 271,350 | +55.1% | 0.37% | +67.1% |
| Q2 2020 | $1,085,000 | – | 175,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 8,748,629 | $15,923,000 | 0.66% |
| Soleus Capital Management, L.P. | 2,640,539 | $4,806,000 | 0.65% |
| Omega Fund Management, LLC | 328,196 | $597,000 | 0.22% |
| MPM BioImpact LLC | 405,700 | $738,000 | 0.18% |
| Bellevue Group AG | 5,898,583 | $10,736,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 375,000 | $1,350,000 | 0.14% |
| PFM Health Sciences, LP | 1,478,252 | $2,690,000 | 0.10% |
| Frazier Life Sciences Management, L.P. | 692,910 | $1,261,000 | 0.10% |
| Avidity Partners Management LP | 2,460,000 | $4,477,000 | 0.09% |
| Eventide Asset Management | 1,561,251 | $2,841,000 | 0.06% |